AusPAR: Mepolizumab
Australian Public Assessment Report
Device/Product Name
Nucala
Active ingredients
Mepolizumab
AusPAR Date
Published
Submission Number
PM-2017-04349-1-5
Submission Type
Extension of indications
Decision
Approved